803 related articles for article (PubMed ID: 16951986)
1. Transforming growth factor-beta in cancer and metastasis.
Jakowlew SB
Cancer Metastasis Rev; 2006 Sep; 25(3):435-57. PubMed ID: 16951986
[TBL] [Abstract][Full Text] [Related]
2. The role for transforming growth factor-beta (TGF-beta) in human cancer.
Gold LI
Crit Rev Oncog; 1999; 10(4):303-60. PubMed ID: 10654929
[TBL] [Abstract][Full Text] [Related]
3. Actions of TGF-beta as tumor suppressor and pro-metastatic factor in human cancer.
Pardali K; Moustakas A
Biochim Biophys Acta; 2007 Jan; 1775(1):21-62. PubMed ID: 16904831
[TBL] [Abstract][Full Text] [Related]
4. Transforming growth factor-beta: a target for cancer therapy.
Kelly RJ; Morris JC
J Immunotoxicol; 2010 Mar; 7(1):15-26. PubMed ID: 19916703
[TBL] [Abstract][Full Text] [Related]
5. Loss of growth regulation by transforming growth factor-beta (TGF-beta) in human cancers: studies on endometrial carcinoma.
Gold LI; Parekh TV
Semin Reprod Endocrinol; 1999; 17(1):73-92. PubMed ID: 10406078
[TBL] [Abstract][Full Text] [Related]
6. Tumor-suppressive and promoting function of transforming growth factor beta.
Sun L
Front Biosci; 2004 May; 9():1925-35. PubMed ID: 14977598
[TBL] [Abstract][Full Text] [Related]
7. TGF-β Signaling in Cancer.
Syed V
J Cell Biochem; 2016 Jun; 117(6):1279-87. PubMed ID: 26774024
[TBL] [Abstract][Full Text] [Related]
8. TGF-beta signaling in tumor suppression and cancer progression.
Derynck R; Akhurst RJ; Balmain A
Nat Genet; 2001 Oct; 29(2):117-29. PubMed ID: 11586292
[TBL] [Abstract][Full Text] [Related]
9. SD-208, a novel transforming growth factor beta receptor I kinase inhibitor, inhibits growth and invasiveness and enhances immunogenicity of murine and human glioma cells in vitro and in vivo.
Uhl M; Aulwurm S; Wischhusen J; Weiler M; Ma JY; Almirez R; Mangadu R; Liu YW; Platten M; Herrlinger U; Murphy A; Wong DH; Wick W; Higgins LS; Weller M
Cancer Res; 2004 Nov; 64(21):7954-61. PubMed ID: 15520202
[TBL] [Abstract][Full Text] [Related]
10. TGF-β signaling in cancer metastasis.
Xie F; Ling L; van Dam H; Zhou F; Zhang L
Acta Biochim Biophys Sin (Shanghai); 2018 Jan; 50(1):121-132. PubMed ID: 29190313
[TBL] [Abstract][Full Text] [Related]
11. TGF-beta in CAF-mediated tumor growth and metastasis.
Calon A; Tauriello DV; Batlle E
Semin Cancer Biol; 2014 Apr; 25():15-22. PubMed ID: 24412104
[TBL] [Abstract][Full Text] [Related]
12. TGF-beta and cancer.
Bierie B; Moses HL
Cytokine Growth Factor Rev; 2006; 17(1-2):29-40. PubMed ID: 16289860
[TBL] [Abstract][Full Text] [Related]
13. Transforming growth factor beta and fibroblast growth factor as promoters of tumor progression to malignancy.
Wright JA; Turley EA; Greenberg AH
Crit Rev Oncog; 1993; 4(5):473-92. PubMed ID: 8241321
[TBL] [Abstract][Full Text] [Related]
14. Role of transforming growth factor-beta in cancer progression.
Galliher AJ; Neil JR; Schiemann WP
Future Oncol; 2006 Dec; 2(6):743-63. PubMed ID: 17155901
[TBL] [Abstract][Full Text] [Related]
15. The dynamic roles of TGF-β in cancer.
Meulmeester E; Ten Dijke P
J Pathol; 2011 Jan; 223(2):205-18. PubMed ID: 20957627
[TBL] [Abstract][Full Text] [Related]
16. Role of transforming growth factor beta in cancer.
Pasche B
J Cell Physiol; 2001 Feb; 186(2):153-68. PubMed ID: 11169452
[TBL] [Abstract][Full Text] [Related]
17. Transforming growth factor beta signaling is disabled early in human endometrial carcinogenesis concomitant with loss of growth inhibition.
Parekh TV; Gama P; Wen X; Demopoulos R; Munger JS; Carcangiu ML; Reiss M; Gold LI
Cancer Res; 2002 May; 62(10):2778-90. PubMed ID: 12019154
[TBL] [Abstract][Full Text] [Related]
18. TGF-beta signaling in cancer treatment.
Fabregat I; Fernando J; Mainez J; Sancho P
Curr Pharm Des; 2014; 20(17):2934-47. PubMed ID: 23944366
[TBL] [Abstract][Full Text] [Related]
19. TGF-beta1 acts as a tumor suppressor of human malignant keratinocytes independently of Smad 4 expression and ligand-induced G(1) arrest.
Paterson IC; Davies M; Stone A; Huntley S; Smith E; Pring M; Eveson JW; Robinson CM; Parkinson EK; Prime SS
Oncogene; 2002 Feb; 21(10):1616-24. PubMed ID: 11896591
[TBL] [Abstract][Full Text] [Related]
20. TGF-beta switches from tumor suppressor to prometastatic factor in a model of breast cancer progression.
Tang B; Vu M; Booker T; Santner SJ; Miller FR; Anver MR; Wakefield LM
J Clin Invest; 2003 Oct; 112(7):1116-24. PubMed ID: 14523048
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
